Skip to main content

Defeat Myeloma

Sun June 30, 2024 Seattle, WA 98115 US
B
Fundraiser

Beth Bisignano

Fundraiser Login
Donate

$250

Raised of $10

$0
$10

Story

Welcome to my fundraising page!

I am participating in the 2024 Defeat Multiple Myeloma Run/Walk on Sunday, June 30. Each donation plays a part in bringing myeloma treatment options to patients faster and helping fund research to find a cure for this cancer. Together, we are building community, supporting survivors, remembering loved ones lost, and funding research that is giving new hope to patients. We are committed, we are strong, and our impact can be enormous.

Please join me in this fight and increase our impact by making a donation to my page today; 100% of all funds raised will go directly to advancing multiple myeloma cancer research at Fred Hutchinson Cancer Research Center.

What is Multiple Myeloma? 

Multiple Myeloma is a cancer of plasma cells found in bone marrow.  Normal plasma cells help the immune system fight disease, but when plasma cells become cancerous they grow out of control and can produce a tumor called a plasmacytoma.  If someone has more than one plasmacytoma, they have multiple myeloma.

Why support this event?

Defeat Multiple Myeloma’s mission is to raise awareness of multiple myeloma while supporting research that seeks to discover new treatments, improve the quality of life for myeloma patients, and ultimately find a cure for this devastating form of cancer. Funds from the 2024 Defeat Multiple Myeloma event will continue to support immunotherapy research and clinical trials at Fred Hutch which are using CAR-T cells and have shown very promising early results for patients.

Recognitions

$50
$100
$250
5
10
15
20
50
$500
$750
$1,000
$2,500
$5,000
$10,000
$25,000

Top Donors

$250 Raised By 1 Donor

$250 on behalf of Beth Bisignano

If you continue to use this site, you consent to use all cookies. We use cookies to offer you a better browsing experience. Read how we use cookies and how you can control them by visiting our Privacy Policy.

If you continue to use this site, you consent to use all cookies.